Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1982 Oct;41(5):444–446. doi: 10.1136/ard.41.5.444

High-dose intravenous methylprednisolone in rheumatoid arthritis.

P J Forster, K A Grindulis, V Neumann, S Hubball, B McConkey
PMCID: PMC1001018  PMID: 7125712

Abstract

Fourteen patients with severe rheumatoid arthritis (RA) were given 27 courses of methylprednisolone intravenously, each of 3 infusions of 1 g on alternate days. After 7 days there was marked improvement in clinical state and most laboratory tests; levels of ESR and 4 serum acute-phase proteins, C3, C, IgG, and IgA, fell significantly. Serum IgM and rheumatoid factor titre were unchanged. 125I C1q binding fell in all instances where it was initially raised. Clinical remission lasted a mean of 10 weeks. Serum C-reactive protein (CRP) fell to less than 30 mg/l after all courses except one within 7 days and rose above this figure after a mean of 7 weeks. The ESR fell below 30 mm/h within seven days in 17 courses and remained below this value for a mean of 7 weeks. Three patients had clinical remissions, with serum CRP less than 30 mg/l and ESR less than 30 mm/h, lasting more than 42 weeks.

Full text

PDF
444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FINCH S. C., CROCKETT C. L., Jr, ROSS J. F., BAYLES T. B. Hematologic changes with ACTH and cortisone therapy of rheumatoid arthritis. Blood. 1951 Nov;6(11):1034–1050. [PubMed] [Google Scholar]
  2. Hunder G. G., McDuffie F. C. Hypocomplementemia in rheumatoid arthritis. Am J Med. 1973 Apr;54(4):461–472. doi: 10.1016/0002-9343(73)90042-9. [DOI] [PubMed] [Google Scholar]
  3. Liebling M. R., Leib E., McLaughlin K., Blocka K., Furst D. E., Nyman K., Paulus H. E. Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med. 1981 Jan;94(1):21–26. doi: 10.7326/0003-4819-94-1-21. [DOI] [PubMed] [Google Scholar]
  4. McConkey B., Crockson R. A., Crockson A. P. The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants. Q J Med. 1972 Apr;41(162):115–125. [PubMed] [Google Scholar]
  5. McConkey B., Crockson R. A., Crockson A. P., Wilkinson A. R. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. Q J Med. 1973 Oct;42(168):785–791. [PubMed] [Google Scholar]
  6. McConkey B., Davies P., Crockson R. A., Crockson A. P., Butler M., Constable T. J., Amos R. S. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis. 1979 Apr;38(2):141–144. doi: 10.1136/ard.38.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Versey J. M., Hobbs J. R., Holt P. J. Complement metabolism in rheumatoid arthritis. I. Longitudinal studies. Ann Rheum Dis. 1973 Nov;32(6):557–564. doi: 10.1136/ard.32.6.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES